Source: International Congress 2016 – Airway response to infection
Disease area: Airway diseases, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Jessica Tilman (London, United Kingdom), Jessica Tilman, Peter Barnes, Louise Donnelly. Colony stimulating factors cannot correct defective phagocytosis in COPD lung tissue macrophages. Eur Respir J 2016; 48: Suppl. 60, 3974

Member's Comments

No comment yet.

Related content which might interest you: Relationship between monocyte-derived macrophage phagocytosis and airway inflammation in stable COPD Source: Annual Congress 2013 –COPD: experimental biology Year: 2013 COPD exacerbation severity is associated with impaired macrophage phagocytosis of eosinophils Source: Annual Congress 2013 –Cell biology and murine models of asthma and inflammation Year: 2013 Characterisation of defective phagocytosis by chronic obstructive pulmonary disease alveolar macrophages Source: International Congress 2016 – New findings in mucosal immunology Year: 2016 The effect of in vitro culture methods on corticosteroid sensitivity in COPD alveolar macrophages Source: Annual Congress 2013 –COPD: experimental biology Year: 2013 Relationship of monocyte-derived macrophage phagocytosis to exacerbation susceptibility in stable COPD Source: International Congress 2014 – COPD - from biomarkers to novel therapeutic opportunities Year: 2014 TNFalpha release by monocyte-derived macrophages at stable and exacerbation states in COPD Source: International Congress 2014 – COPD physiopathology Year: 2014 Increased circulating alveolar epithelial microparticles in COPD patients Source: International Congress 2015 – Modulating the immune system in COPD and asthma Year: 2015 Effects of dexamethasone and anti-inflammatory drugs on inflammatory cytokines from bronchial epithelial cells of COPD patients Source: International Congress 2015 – New insights into lung disease pathogenesis Year: 2015 Increased uptake of haemophilus influenzae by primary airway epithelial cells from COPD patients Source: International Congress 2016 – New signalling pathways in COPD Year: 2016 Neutrophil extracellular traps (NETs) in COPD: A potential novel mechanism for host damage in acute exacerbations Source: International Congress 2015 – Cellular and molecular mechanisms of COPD and emphysema Year: 2015 M2 macrophage marker CD163, CD204 and CD206 expression on alveolar macrophages in the lung of patients with chronic obstructive pulmonary Source: International Congress 2014 – New insights into monocyte and macrophage biology Year: 2014 Reduced phagocytosis of bacterial pathogens by macrophages from COPD patients Source: Annual Congress 2010 - Macrophages: cell biology and disease-specific characteristics Year: 2010 Monocyte-derived macrophages from non-smoker COPD subjects exhibit defective bacterial phagocytosis Source: International Congress 2015 – Mucosal immunology: what’s new in 2015 Year: 2015 Quantitative analysis of potentially pathogenic microbes (PPMs) in the induced sputum of non-smoker COPD (NS-COPD) subjects Source: International Congress 2016 – Clinical and microbiological aspects of infections in COPD patients Year: 2016 The relationship between blood eosinophils and bacterial load in COPD patients Source: International Congress 2016 – What's new in biomarker analysis? Year: 2016 Altered inflammasome activity in bacterial acute exacerbations of COPD (AECOPD) Source: Annual Congress 2013 –Biomarkers in asthma and COPD Year: 2013 Neutrophil numbers are decreased in bronchial biopsies from patients with COPD Source: Annual Congress 2013 –COPD: new markers of diseases Year: 2013 Altered expression of glycosaminoglycans in the BAL of COPD patients with acute exacerbation Source: Annual Congress 2013 –Translational studies in chronic lung diseases: from bedside to bench Year: 2013 COPD monocytes differentiate into pro-inflammatory macrophages regardless of environment Source: Annual Congress 2013 –Macrophages, mononuclear cells and viral infection Year: 2013 Macrolide effects on the prevention of COPD exacerbations Source: Eur Respir J 2012; 40: 485-494 Year: 2012